Establishing secure connection…Loading editor…Preparing document…

Research Collaboration Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH COLLABORATION AGREEMENT

This Research Collaboration Agreement ("Agreement") is entered into as of Effective Date: by and between Party A Name: and Party B Name: .

WHEREAS

WHEREAS, Party A is engaged in research, development, or educational activities in the field described in the Scope of Work below and possesses facilities, personnel, and expertise suitable for conducting the project; and

WHEREAS, Party B has complementary expertise, resources, or funding and desires to collaborate with Party A to undertake the Project described herein on the terms and conditions set forth in this Agreement; and

WHEREAS, the Parties intend to set forth their respective responsibilities, financial arrangements, intellectual property rights, publication procedures and confidentiality obligations in this Agreement.

PARTIES' CONTACT AND IDENTIFYING INFORMATION

SCOPE OF WORK

The Parties shall collaborate to undertake the research project described below (the "Project"). The collaboration shall include planning, data collection, analysis, and reporting as specified in the deliverables. Specific tasks, milestones and responsible Party are described in the Scope of Work field.

PAYMENT TERMS

In consideration for performance of the Scope of Work, the Funding Party shall pay compensation as set forth below. Absent an express written amendment, obligations to pay shall survive termination only as set forth in this Agreement.

Late payments shall incur a late fee equal to percent per month, or the maximum permitted by applicable law if lower. Interest shall accrue from the date payment was due until paid in full.

TERM AND TERMINATION

This Agreement shall commence on Start Date: and shall continue until End Date: unless earlier terminated in accordance with this Agreement.

Either Party may terminate this Agreement for material breach by the other Party if the breach remains uncured for a period of days after receipt of written notice specifying the breach. Either Party may terminate for convenience upon days' prior written notice to the other Party. Termination shall not relieve either Party of obligations accrued prior to termination.

CONFIDENTIALITY

Each Party may disclose to the other Party certain confidential or proprietary information ("Confidential Information"). Confidential Information does not include information that: (a) is or becomes publicly known through no breach of this Agreement; (b) is rightfully received from a third party without restriction; (c) is independently developed by the receiving Party without use of the disclosing Party's Confidential Information; or (d) is required to be disclosed by law or regulation subject to prior notice to the disclosing Party where lawful.

The receiving Party shall: (i) hold Confidential Information in confidence using at least the same degree of care it uses to protect its own confidential information but no less than reasonable care; (ii) use Confidential Information only for the purposes of performing this Agreement; and (iii) limit access to Confidential Information to employees, agents or contractors who have a need to know and who are bound to confidentiality obligations no less protective than those set forth herein.

INTELLECTUAL PROPERTY

Pre-existing intellectual property owned or controlled by a Party prior to the Effective Date ("Background IP") shall remain vested in the owning Party. Subject to any separate written agreement, Intellectual Property first conceived, developed or reduced to practice by one Party solely in the performance of the Project ("Foreground IP") shall be owned by the inventing Party. Intellectual Property first conceived, developed or reduced to practice jointly by employees or agents of both Parties shall be joint property and the Parties shall cooperate in good faith to determine filing, prosecution and maintenance of any patents or other protection.

Each Party grants to the other Party a non-exclusive, royalty-free license to use Background IP to the extent necessary to perform the Scope of Work and to exercise rights granted in this Agreement, subject to any restrictions agreed in writing.

PUBLICATION; PRESENTATION

The Parties recognize the value of timely publication of research results. Each Party shall have the right to publish or present the results of the Project, subject to the other Party's right to review any proposed manuscript or presentation containing Confidential Information or patentable subject matter. Prior to submission, the publishing Party shall provide the other Party with a copy for review at least days in advance. Review shall be limited to legitimate protection of confidential information or the filing of patent applications; review shall not be used to unreasonably withhold or delay publication.

DATA HANDLING AND SECURITY

INDEMNIFICATION; LIMITATION OF LIABILITY

Each Party shall indemnify, defend and hold harmless the other Party and its officers, employees and agents from and against all claims, liabilities, losses, costs and expenses (including reasonable attorneys' fees) arising out of the indemnifying Party's negligent acts or willful misconduct in the performance of this Agreement. Neither Party shall be liable to the other for indirect, incidental, consequential or punitive damages, except to the extent such damages arise from willful misconduct or gross negligence.

COMPLIANCE WITH LAWS

Each Party represents and warrants that it shall perform its obligations under this Agreement in compliance with all applicable laws, regulations, and institutional rules, including applicable export control, human subjects, animal welfare, and biosafety laws and policies. Each Party shall obtain and maintain, at its own expense, all permits, approvals and institutional or ethical clearances required for its performance of the Scope of Work.

AMENDMENT; ASSIGNMENT

This Agreement may be amended only by a written instrument signed by authorized representatives of both Parties. Neither Party may assign this Agreement or any rights hereunder without the prior written consent of the other Party, except that either Party may assign to an affiliate or successor in connection with a merger, sale or reorganization provided that the assignee assumes all obligations hereunder.

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to its conflicts of law principles.

ENTIRE AGREEMENT

This Agreement, including any attachments or statements of work explicitly incorporated herein, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations and discussions, whether oral or written, of the Parties relating thereto.

If any provision of this Agreement is held to be invalid, illegal or unenforceable, the remaining provisions shall remain in full force and effect and the Parties shall negotiate in good faith to replace the invalid provision with a valid provision that most closely approximates the Parties' original intent.

Party A - Printed Name:

By:

Date:

Title:

Party B - Printed Name:

By:

Date:

Title:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What a Research Collaboration Agreement Is and When It Applies

A Research Collaboration Agreement is a legally binding contract that sets the terms for cooperative research between two or more parties, such as universities, companies, hospitals, or government laboratories. Typical provisions define the project scope, responsibilities, deliverables, funding, intellectual property ownership and licensing, publication rights, confidentiality, data sharing and security, regulatory compliance (including IRB and HIPAA where applicable), dispute resolution, and termination. The agreement clarifies timelines, budget obligations, reporting requirements, and who has authority to sign on behalf of each organization, reducing ambiguity before work begins.

Why this Agreement Matters for Research Projects

A clear Research Collaboration Agreement reduces legal and operational risk, protects intellectual property, and aligns expectations for deliverables, funding, data handling, and publication. It helps sponsors and investigators manage compliance, preserve rights, and avoid later disputes.

Why this Agreement Matters for Research Projects

Who Typically Enters into a Research Collaboration Agreement

Common signatories include academic institutions, commercial partners, non-profit research organizations, and government agencies, each bringing different priorities for IP, data, and publication.

  • Academic institutions with faculty-led projects and university technology transfer offices
  • Biotech, pharmaceutical, and device companies funding or performing joint research
  • Hospitals and clinical research organizations handling patient data

Tailor the agreement language and approval workflow to the dominant party type and applicable compliance obligations before execution.

Representative Signer Profiles

Principal Investigator

Typically a faculty researcher or lab director who manages project execution, protocol compliance, data collection, and reporting. The PI signs operational sections and secures institutional approvals but may not have authority to bind the institution on IP or funding terms.

Executive Signatory

An authorized institutional officer (e.g., VP research, contracts officer, general counsel designee) who has legal authority to accept funding terms, approve IP licensing allocations, and bind the organization to indemnities and payment schedules.

Core Sections to Include in a Professional Agreement

A complete Research Collaboration Agreement groups rights and obligations into discrete, negotiable sections so each party’s expectations are explicit and enforceable.

Parties & Scope

Identify the legal entities, project objectives, milestones, deliverables, and geographic or programmatic limits. Precise scope reduces future disputes about out‑of‑scope work.

Funding & Budget

Detail payment amounts, invoicing schedule, allowable expenses, overhead treatment, and consequences of missed payments or budget overruns to avoid later funding disagreements.

Intellectual Property

Allocate ownership of background IP and project IP; specify assignment, licensing rights, commercialization pathway, and patent prosecution responsibilities.

Publication Rights

Set procedures for manuscript review, sponsor delays for proprietary data, co‑authorship expectations, and permitted embargo periods to balance academic dissemination and commercial interests.

Data Use & Security

Establish data formats, access rights, PHI handling, encryption and storage requirements, permitted secondary use, and breach notification processes.

Compliance & Termination

Include IRB approvals, regulatory ownership, liability caps, indemnities, dispute resolution mechanisms, termination triggers, and transition obligations on closure.

Step‑by‑Step: From Draft to Fully Executed Agreement

Follow a structured process that separates legal review, compliance checks, and administrative approvals to speed execution and reduce rework.

  • 01
    Draft Agreement: Prepare a draft using standard institutional templates and project specifics.
  • 02
    Internal Review: Route to legal, tech transfer, and finance for IP and budget approval.
  • 03
    External Negotiation: Exchange redlines and finalize IP, publication, and payment terms.
  • 04
    Execution: Collect authorized signatures, retain executed copy, and confirm distribution to parties.

Setting Up an Efficient Online Signing Workflow

Design a signing workflow that enforces order, captures audit data, and integrates with institutional systems for storage and compliance.

Field Configuration
Authentication Email link with optional SMS code or 2FA for higher assurance
Templates Create reusable templates for recurring clause sets and budget tables
Routing Order Set sequential or parallel signing to reflect required approvals
Retention Export signed PDFs to secure records management or institutional repository

How Electronic Execution Typically Works

The online signing process captures intent, attribution, and a tamper‑evident record while removing the need for paper circulation.

  • Prepare: Upload final PDF and place signature fields
  • Invite: Send to parties by email or secure link
  • Authenticate: Use email, SMS, or stronger methods for signer verification
  • Complete: Collect signatures and distribute final signed copies

Technical Considerations for eSigning and Distribution

Confirm integrations with storage, IRB systems, or contract repositories to automate retention and access controls after signing.

  • Data Encryption: AES‑256 at rest, TLS 1.2/1.3 in transit
  • Audit Trail: Capture IP, timestamps, and signer actions
  • File Formats: PDF/A and DOCX support for archival and editing

Common Deadlines and Reporting Expectations

Research projects include multiple date‑driven obligations; document them clearly and align institutional calendars to avoid compliance lapses.

IRB Approval Timeline:

Obtain prior to human subject work; timelines vary by protocol complexity

Funding Milestones:

Align invoicing and deliverable dates with sponsor payment schedules

Progress Reports:

Report frequency (quarterly/annual) and submission format specified by sponsor

Publication Embargo:

Sponsor review windows and permitted embargo durations

Agreement Renewal:

Set notice periods for renewal or termination before contract expiration

Key Project Milestones from Agreement to Closeout

Map high‑level milestones to ensure administrative, scientific, and financial tasks occur in sequence and on time.

01

Execution

Signatures obtained and countersigned; repository updated

02

Project Start

Work begins after IRB and funding confirmations

03

Midterm Review

Progress assessed against deliverables and budget

04

Closeout

Final reports, IP disposition, and archival of records

Common Mistakes to Avoid When Preparing the Agreement

  • Ambiguous IP language that fails to allocate ownership and licensing rights clearly, leading to later disputes or litigation
  • Neglecting IRB or human subjects approvals before work begins, which can halt projects and risk compliance violations
  • Using signatories without institutional authority, producing delays when execution must be re‑done by an authorized officer
  • Failing to define data security measures for PHI and sensitive data, increasing breach risk and regulatory liability

Potential Consequences of Errors or Noncompliance

IP Disputes: Costly litigation and lost commercialization revenue
Funding Loss: Sponsor may suspend or terminate payments
Regulatory Fines: HIPAA or other fines for improper PHI handling
Reputational Harm: Damaged relationships with collaborators and funders
Project Delays: Work stoppages from missing approvals
Contract Voidance: Invalid execution may render agreement unenforceable

Security and Compliance Checklist for Research Data

HIPAA: BAA required
Encryption: AES‑256 recommended
Audit Trail: Preserve signer logs
Access Controls: Role‑based permissions
De‑identification: Use for secondary analyses
IRB Approval: Documented and current

Practical Examples of Research Collaboration Uses

Two typical scenarios illustrate how agreements are structured and the clauses that matter most to each party.

University–Industry Partnership

A university lab and a biotech company collaborate on preclinical studies with company funding and university expertise

  • Sponsor requests a 45‑day review period before publications
  • The agreement assigns project IP to the university while granting the sponsor an exclusive license option for commercial use, plus milestone payments tied to deliverables and patent filing responsibilities.

Hospital Clinical Research

A hospital and a device manufacturer run a clinical feasibility study under an IRB protocol

  • The hospital requires BAA and data use agreements
  • The contract restricts PHI sharing, sets monitoring responsibilities, defines adverse event reporting, and clarifies the sponsor’s role in publication review without unreasonable delays.

How a Research Collaboration Agreement Differs from Similar Documents

Compare closely related documents to ensure you choose the right instrument for the relationship and protect the parties appropriately.

Document Type Research Collaboration Confidentiality Agreement
Purpose joint research and ip protects disclosed confidential information
IP Provisions detailed ownership and licensing limited or absent
Funding Terms includes budget and payment schedule typically none
Regulatory Clauses irb, hipaa, export control rarely present

Typical eSignature Pricing and Feature Snapshot for Executing Agreements

Evaluate vendor pricing and capabilities against your anticipated signing volume, need for a BAA, and required advanced features before selecting a platform.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7‑day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Frequently Asked Questions About Execution and Compliance

Answers to common questions about eSigning, authority to sign, PHI handling, amendments, and recordkeeping for research agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.